As an example, in small cell lung cancer (SCLC), activation of MET with HGF leads to phosphorylation/activation of several pathways involving cell proliferation/survival (ERK1/2, AKT), cell cycle (RB), and cytoskeletal proteins (paxillin, FAK).[39]. Here, AKT1 is linked to small cell lung carcinoma.